Altimmune (ALT) Non-Current Assets (2010 - 2026)

Altimmune (ALT) has 17 years of Non-Current Assets data on file, last reported at $954000.0 in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 52.32% year-over-year to $954000.0 in Q1 2026; TTM through Mar 2026 was $6.5 million, a 22.45% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 15.35% from the prior year.
• Non-Current Assets for Q1 2026 stood at $954000.0, down from $1.7 million in the prior quarter.
• Over the last five years, Non-Current Assets for ALT reached as high as $14.6 million in Q1 2022 and fell as low as $843000.0 in Q1 2024.
• Historically, Non-Current Assets has averaged $6.8 million across 5 years, with a median of $2.1 million in 2024.
• Across the five-year window, Non-Current Assets sank 93.97% in 2024 and soared 137.37% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $14.1 million in 2022, then plunged by 92.82% to $1.0 million in 2023, then surged by 102.37% to $2.1 million in 2024, then declined by 15.35% to $1.7 million in 2025, then tumbled by 45.08% to $954000.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $954000.0 in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.